Stockreport

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

Tourmaline Bio, Inc.  (TRML) 
PDF NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative med [Read more]